Table 2 Parasitological data at enrolment
N | N (%)a | p/μL, (IQR)b | N (%)c | p/μL, (IQR)d | |
|---|---|---|---|---|---|
Overall | 265 | 176/265 (66.4) | 3328 (940,12260) | 46/265 (17.4) | 94.1 (40,120) |
AL | 133 | 92/133 (69.2) | 4016.0 (1180,1500) | 31/133 (23.3) | 102.0 (40,120) |
Placebo | 132 | 84/132 (64.0) | 2710.3 (860,10660) | 15/132 (11.4) | 80.0 (40,120) |
Bed net users | 86 | 50/86 (58.1) | 2916.0 (880,10440) | 20/86 (23.3) | 112.0 (40,140) |
Bed net non users | 179 | 126/179 (70.4) | 3509.0 (960,13080) | 26/179 (15.0) | 83.0 (40,120) |
Age 12–23 mo | 89 | 46/89 (52.0) | 3296.0 (840,14560) | 14/89 (16) | 100.0 (40,120) |
Age 24–35 mo | 88 | 63/88 (72.0) | 3067.0 (720,10480) | 17/88 (19.3) | 101.0 (40,120) |
Age 36–47 mo | 88 | 67/88 (76.1) | 3620.3 (1440,12480) | 15/88 (17.1) | 75.2 (40,120) |
Anemic | 60 | 42/60 (70) | 4373.3 (1760,13360) | 8/60 (13.3) | 115.4 (40,100) |
Not anemic | 194 | 128/194 (66.0) | 3117.0 (780,12720) | 37/194 (19.1) | 92.2 (40,120) |